| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |